Breast cancer drugs battle disease's return

A pair of drugs already on the market appear to reduce the recurrence of breast cancer in women who’ve already undergone treatment, two new clinical trials show. The chemotherapy drug capecitabine seems to reduce by nearly a third the risk of breast cancer...